10 stories from 7 sources
Supporting Articles
The FDA has dropped its earlier objections and told UniQure it can proceed with submitting its experimental Huntington’s disease therapy for approval. The decision reopens a regulatory path for a high-profile program that had been stalled by agency concerns.
7:43 AMStat NewsUniQure says the FDA will let it pursue US approval for its Huntington’s disease gene therapy without first running a new clinical study. The decision reverses an earlier stance and triggered a sharp jump in UniQure’s shares.
7:27 AMBloomberg MarketsHealth officials warn the latest Ebola outbreak could become the worst on record because transmission is outpacing case finding and contact tracing. A sharp drop in international funding is limiting surveillance, staffing, and basic outbreak control.
12:15 PMAl JazeeraThe FTC and attorneys general from four states sued the leading professional association for clinicians who provide gender-affirming care. The case challenges the group’s role in setting clinical standards and influencing how providers and insurers deliver and cover this care.
2:23 PMStat NewsSummary
The FDA has dropped its earlier objections and told UniQure it can proceed with submitting its experimental Huntington’s disease therapy for approval. The decision reopens a regulatory path for a high-profile program that had been stalled by agency concerns.
Why it matters
It changes the probability that a disease-modifying Huntington’s treatment could reach the market and signals how the FDA may handle disputed evidence in neurology gene-therapy programs.
Summary
UniQure says the FDA will let it pursue US approval for its Huntington’s disease gene therapy without first running a new clinical study. The decision reverses an earlier stance and triggered a sharp jump in UniQure’s shares.
Why it matters
FDA willingness to approve without new trials can accelerate treatments and investment, but it also resets the evidentiary bar for gene therapies with serious safety and durability questions.
Summary
Health officials warn the latest Ebola outbreak could become the worst on record because transmission is outpacing case finding and contact tracing. A sharp drop in international funding is limiting surveillance, staffing, and basic outbreak control.
Why it matters
When Ebola spreads faster than it can be traced, containment fails and a local outbreak can turn into a regional crisis.
Summary
The FTC and attorneys general from four states sued the leading professional association for clinicians who provide gender-affirming care. The case challenges the group’s role in setting clinical standards and influencing how providers and insurers deliver and cover this care.
Why it matters
It puts the legal status of medical guideline-making in the crosshairs and could reshape access, coverage, and liability around gender-affirming care nationwide.
A curated list of other prominent stories from this day.
Midjourney is moving beyond image generation into physical products with an ultrasound-based full-body scanner called the Midjourney Scanner. The company also plans to build a San Francisco spa built around the scanning experience.
11:12 PMThe VergeRFK Jr. is promoting about $700 million in federal funding aimed at mental illness and addiction, with an emphasis on people experiencing homelessness. Experts note the money largely reflects existing grant programs rather than new, additive funding.
5:36 PMStat NewsNorway’s Crown Princess Mette-Marit received a lung transplant after years living with pulmonary fibrosis. She had recently been placed on an organ waiting list as her condition progressed.
10:20 AMThe New York TimesA cyber extortion group says it stole more than a terabyte of data from Novo Nordisk. The group claims it is considering selling some of the data to increase pressure on the company.
9:09 AMStat NewsNorway's Crown Princess Mette-Marit has undergone a successful lung transplant after living with pulmonary fibrosis. The palace said she will remain in hospital for several weeks for recovery.
6:15 AMBBCA minimally invasive knee procedure that blocks inflammation-feeding blood vessels reduced osteoarthritis pain and improved function, with benefits lasting at least 12 months. The study reports the approach was safe and highly successful, positioning it as a potential option before knee replacement.
12:46 AMScienceDailySummary
Midjourney is moving beyond image generation into physical products with an ultrasound-based full-body scanner called the Midjourney Scanner. The company also plans to build a San Francisco spa built around the scanning experience.
Why it matters
An AI image startup entering body scanning could normalize consumer-facing medical imaging while forcing a new level of regulation, privacy protection, and product accountability.
Summary
RFK Jr. is promoting about $700 million in federal funding aimed at mental illness and addiction, with an emphasis on people experiencing homelessness. Experts note the money largely reflects existing grant programs rather than new, additive funding.
Why it matters
Communities facing surging behavioral health needs may get headlines without meaningful new resources unless the funding is truly incremental and operationally usable.
Summary
Norway’s Crown Princess Mette-Marit received a lung transplant after years living with pulmonary fibrosis. She had recently been placed on an organ waiting list as her condition progressed.
Why it matters
It puts a spotlight on pulmonary fibrosis outcomes and the real constraint in transplantation: scarce donor organs and high-stakes allocation decisions.
Summary
A cyber extortion group says it stole more than a terabyte of data from Novo Nordisk. The group claims it is considering selling some of the data to increase pressure on the company.
Why it matters
Data theft plus resale threats can turn a contained breach into a market and compliance crisis within days.
Summary
Norway's Crown Princess Mette-Marit has undergone a successful lung transplant after living with pulmonary fibrosis. The palace said she will remain in hospital for several weeks for recovery.
Why it matters
It puts a rare, high stakes treatment for end stage lung disease into the public eye and can influence awareness and attitudes toward transplant care and organ donation.
Summary
A minimally invasive knee procedure that blocks inflammation-feeding blood vessels reduced osteoarthritis pain and improved function, with benefits lasting at least 12 months. The study reports the approach was safe and highly successful, positioning it as a potential option before knee replacement.
Why it matters
A safe, durable non-surgical option could delay or reduce knee replacements and reshape treatment pathways for a high-volume, high-cost condition.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!